A detailed history of Nuveen, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 798,807 shares of PGEN stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
798,807
Previous 495,527 61.2%
Holding current value
$3.68 Million
Previous $703,000 273.83%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$1.43 - $4.76 $433,690 - $1.44 Million
303,280 Added 61.2%
798,807 $2.63 Million
Q2 2025

Aug 12, 2025

BUY
$1.17 - $1.62 $363,471 - $503,267
310,659 Added 168.04%
495,527 $703,000
Q1 2025

May 12, 2025

BUY
$1.07 - $2.03 $197,808 - $375,282
184,868 New
184,868 $275,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $960M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.